Editor's Note: pharmaphorum is an editorially independent publication owned by EVERSANA.

The milestones in xenotransplantation – cross-species transplants – rely on cutting-edge biotechnologies, including the use ...

The discovery by the UK Health Security Agency (UKHSA) raises the possibility that viral diseases that are known to be ...

Ionis' antisense therapy Zanvastro has been approved by the FDA for Alexander disease (AxD), throwing a lifeline to people ...

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...

Interim data from the 393-patient phase 3 CERVINO trial of etentamig (ABBV-383), a bispecific CD3 and BCMA-directed TCE, ...

Denmark's Netcompany has been awarded a five-year contract from NHS England, worth more than £215 million, to build the ...

Shares in China's Hutchmed surged today after GSK paid $110 million upfront for rights to a preclinical-stage KRAS and EGFR-targeted drug with potential in colorectal, pancreatic, and lung cancer.

Novartis has paused eight clinical trials of its experimental CAR-T therapy rapcabtagene autoleucel (rap-cel or YTB323) after ...

PMV Pharma is preparing to file for approval of its oral p53 protein reactivator drug rezatopopt in the first quarter of 2027 ...

The US FDA issued similar warning letters to five different online peptide vendors on 24th August, giving the companies 15 ...

The US Advanced Research Projects Agency for Health (ARPA-H) has awarded $125 million in funding, split across five groups, ...